{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:51:28Z","timestamp":1791985888927,"version":"4.4.0"},"reference-count":88,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T00:00:00Z","timestamp":1469750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010174","name":"University of Colorado","doi-asserted-by":"publisher","award":["Linda Crnic Institute for Down Syndrome"],"award-info":[{"award-number":["Linda Crnic Institute for Down Syndrome"]}],"id":[{"id":"10.13039\/100010174","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA117907"],"award-info":[{"award-number":["R01CA117907"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["MCB-1243522"],"award-info":[{"award-number":["MCB-1243522"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anna and John J. Sie Foundation"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA046934-27"],"award-info":[{"award-number":["P30CA046934-27"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Although it is clear that trisomy 21 causes Down syndrome, the molecular events acting downstream of the trisomy remain ill defined. Using complementary genomics analyses, we identified the interferon pathway as the major signaling cascade consistently activated by trisomy 21 in human cells. Transcriptome analysis revealed that trisomy 21 activates the interferon transcriptional response in fibroblast and lymphoblastoid cell lines, as well as circulating monocytes and T cells. Trisomy 21 cells show increased induction of interferon-stimulated genes and decreased expression of ribosomal proteins and translation factors. An shRNA screen determined that the interferon-activated kinases JAK1 and TYK2 suppress proliferation of trisomy 21 fibroblasts, and this defect is rescued by pharmacological JAK inhibition. Therefore, we propose that interferon activation, likely via increased gene dosage of the four interferon receptors encoded on chromosome 21, contributes to many of the clinical impacts of trisomy 21, and that interferon antagonists could have therapeutic benefits.<\/jats:p>","DOI":"10.7554\/elife.16220","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T07:59:26Z","timestamp":1469779166000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.16220","source":"Crossref","is-referenced-by-count":357,"title":["Trisomy 21 consistently activates the interferon response"],"prefix":"10.7554","volume":"5","author":[{"given":"Kelly D","family":"Sullivan","sequence":"first","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Pharmacology, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, United States"},{"name":"Howard Hughes Medical Institute, Chevy Chase, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah C","family":"Lewis","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Pharmacology, University of Colorado School of Medicine, Aurora, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda A","family":"Hill","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Pharmacology, University of Colorado School of Medicine, Aurora, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahwan","family":"Pandey","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Pharmacology, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, United States"},{"name":"Howard Hughes Medical Institute, Chevy Chase, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leisa P","family":"Jackson","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, United States"},{"name":"Howard Hughes Medical Institute, Chevy Chase, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M","family":"Cabral","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, United States"},{"name":"Howard Hughes Medical Institute, Chevy Chase, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith P","family":"Smith","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Alexander","family":"Liggett","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana B","family":"Gomez","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, United States"},{"name":"Howard Hughes Medical Institute, Chevy Chase, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D","family":"Galbraith","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Pharmacology, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, United States"},{"name":"Howard Hughes Medical Institute, Chevy Chase, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"DeGregori","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Biochemistry and Molecular Genetics, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Pediatrics, University of Colorado School of Medicine, Aurora, United States"},{"name":"Integrated Department of Immunology, University of Colorado School of Medicine, Aurora, United States"},{"name":"Section of Hematology, University of Colorado School of Medicine, Aurora, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-1941","authenticated-orcid":true,"given":"Joaqu\u00edn M","family":"Espinosa","sequence":"additional","affiliation":[{"name":"Linda Crnic Institute for Down Syndrome, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Pharmacology, University of Colorado School of Medicine, Aurora, United States"},{"name":"Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, United States"},{"name":"Howard Hughes Medical Institute, Chevy Chase, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2016,7,29]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1093\/hmg\/ddt017","article-title":"Protein profiles in Tc1 mice implicate novel pathway perturbations in the Down syndrome brain","volume":"22","author":"Ahmed","year":"2013","journal-title":"Human Molecular Genetics"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/dmcn.12868","article-title":"Morbidity and medication in a large population of individuals with Down syndrome compared to the general population","volume":"58","author":"Alexander","year":"2016","journal-title":"Developmental Medicine and Child Neurology"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq--a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"key":"bib4","volume-title":"Http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/","author":"Andrews","year":"2010","unstructured":"Andrews S. 2010. FastQC: A quality control tool for high throughput sequence data. Http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"bib5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/(SICI)1096-9136(199802)15:2<160::AID-DIA537>3.0.CO;2-J","article-title":"Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications","volume":"15","author":"Anwar","year":"1998","journal-title":"Diabetic Medicine"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ncb1225","article-title":"c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription","volume":"7","author":"Arabi","year":"2005","journal-title":"Nature Cell Biology"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/S0022-3476(98)70034-4","article-title":"Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy","volume":"132","author":"Barlow","year":"1998","journal-title":"Journal of Pediatrics"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/emboj\/20.6.1383","article-title":"N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis","volume":"20","author":"Boon","year":"2001","journal-title":"The EMBO Journal"},{"key":"bib9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.6004\/jnccn.2014.0153","article-title":"Solid malignancies in individuals with Down syndrome: a case presentation and literature review","volume":"12","author":"Bratman","year":"2014","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"D685","DOI":"10.1093\/nar\/gkq1039","article-title":"Pathway commons, a web resource for biological pathway data","volume":"39","author":"Cerami","year":"2011","journal-title":"Nucleic Acids Research"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jprot.2015.07.036","article-title":"QPROT: Statistical method for testing differential expression using protein-level intensity data in label-free quantitative proteomics","volume":"129","author":"Choi","year":"2015","journal-title":"Journal of Proteomics"},{"key":"bib12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018493","article-title":"Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21","volume":"6","author":"Costa","year":"2011","journal-title":"PLoS One"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nri3850","article-title":"Aicardi-gouti\u00e8res syndrome and the type I interferonopathies","volume":"15","author":"Crow","year":"2015","journal-title":"Nature Reviews Immunology"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"201ra120","DOI":"10.1126\/scitranslmed.3005983","article-title":"Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model","volume":"5","author":"Das","year":"2013","journal-title":"Science Translational Medicine"},{"key":"bib15","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2015.00708","article-title":"A new cognitive evaluation battery for Down syndrome and its relevance for clinical trials","volume":"6","author":"de Sola","year":"2015","journal-title":"Frontiers in Psychology"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.12688\/f1000research.6735.1","article-title":"Questioned validity of gene expression dysregulated domains in Down's syndrome","volume":"4","author":"Do","year":"2015","journal-title":"F1000Research"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nsmb.1752","article-title":"CDK8 is a positive regulator of transcriptional elongation within the serum response network","volume":"17","author":"Donner","year":"2010","journal-title":"Nature Structural & Molecular Biology"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2013.04.048","article-title":"HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia","volume":"153","author":"Galbraith","year":"2013","journal-title":"Cell"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.nbt.2011.11.016","article-title":"Advances in human proteomics at high scale with the SOMAscan proteomics platform","volume":"29","author":"Gold","year":"2012","journal-title":"New Biotechnology"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S0022-3476(99)70458-0","article-title":"Interferons and cerebral palsy","volume":"134","author":"Grether","year":"1999","journal-title":"Journal of Pediatrics"},{"key":"bib21","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-54","article-title":"Suppression of ribosomal protein synthesis and protein translation factors by Peg-interferon alpha\/ribavirin in HCV patients blood mononuclear cells (PBMC)","volume":"10","author":"Gupta","year":"2012","journal-title":"Journal of Translational Medicine"},{"key":"bib22","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2016.23","article-title":"Low risk of solid tumors in persons with Down syndrome","author":"Hasle","year":"2016","journal-title":"Genetics in Medicine"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1073\/pnas.1507719112","article-title":"Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy","volume":"112","author":"Hathout","year":"2015","journal-title":"PNAS"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1146\/annurev-biochem-060713-035802","article-title":"The scanning mechanism of eukaryotic translation initiation","volume":"83","author":"Hinnebusch","year":"2014","journal-title":"Annual Review of Biochemistry"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cellbi.2008.04.019","article-title":"Effects of small interfering RNAs targeting MAPK1 on gene expression profile in HeLa cells as revealed by microarray analysis","volume":"32","author":"Huang","year":"2008","journal-title":"Cell Biology International"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.archoralbio.2009.07.009","article-title":"Influences of interferon-gamma on cell proliferation and interleukin-6 production in Down syndrome derived fibroblasts","volume":"54","author":"Iwamoto","year":"2009","journal-title":"Archives of Oral Biology"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/NEN.0000000000000083","article-title":"mTOR Hyperactivation in Down syndrome hippocampus appears early during development","volume":"73","author":"Iyer","year":"2014","journal-title":"Journal of Neuropathology & Experimental Neurology"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ebiom.2015.02.015","article-title":"Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor baricitinib","volume":"2","author":"Jabbari","year":"2015","journal-title":"EBioMedicine"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1083\/jcb.36.3.617","article-title":"Inhibition of protein synthesis in noninfected L cells by partially purified interferon preparations","volume":"36","author":"Johnson","year":"1968","journal-title":"Journal of Cell Biology"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/annrheumdis-2014-206478","article-title":"Safety and efficacy of baricitinib at 24\u2005weeks in patients with rheumatoid arthritis who have had an inadequate response to methotrexate","volume":"74","author":"Keystone","year":"2015","journal-title":"Annals of the Rheumatic Diseases"},{"key":"bib31","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2013-14-4-r36","article-title":"TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions","volume":"14","author":"Kim","year":"2013","journal-title":"Genome Biology"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"11198","DOI":"10.1073\/pnas.200372597","article-title":"Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo","volume":"97","author":"Kim","year":"2000","journal-title":"PNAS"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"key":"bib34","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7434191","article-title":"Potential role of JAK-STAT signaling pathway in the neurogenic-to-gliogenic shift in down syndrome brain","volume":"2016","author":"Lee","year":"2016","journal-title":"Neural Plasticity"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nature13200","article-title":"Domains of genome-wide gene expression dysregulation in Down's syndrome","volume":"508","author":"Letourneau","year":"2014","journal-title":"Nature"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/hmg\/ddm086","article-title":"Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities","volume":"16","author":"Li","year":"2007","journal-title":"Human Molecular Genetics"},{"key":"bib38","first-page":"1743","article-title":"Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene","volume":"63","author":"Lindvall","year":"2003","journal-title":"Cancer Research"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/1471-2164-15-624","article-title":"Functional transcriptome analysis of the postnatal brain of the Ts1Cje mouse model for Down syndrome reveals global disruption of interferon-related molecular networks","volume":"15","author":"Ling","year":"2014","journal-title":"BMC Genomics"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biology"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1172\/JCI60455","article-title":"Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of down syndrome","volume":"122","author":"Malinge","year":"2012","journal-title":"Journal of Clinical Investigation"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1182\/blood-2013-05-503011","article-title":"Development of acute megakaryoblastic leukemia in down syndrome is associated with sequential epigenetic changes","volume":"122","author":"Malinge","year":"2013","journal-title":"Blood"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/107999000312612","article-title":"Partial IFN-alpha\/beta and IFN-gamma receptor knockout trisomy 16 mouse fetuses show improved growth and cultured neuron viability","volume":"20","author":"Maroun","year":"2000","journal-title":"Journal of Interferon & Cytokine Research"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0005-2787(78)90038-2","article-title":"Interferon-mediated effect on ribosomal RNA metabolism","volume":"517","author":"Maroun","year":"1978","journal-title":"Biochimica Et Biophysica Acta"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/tera.1420510509","article-title":"Anti-interferon immunoglobulins can improve the trisomy 16 mouse phenotype","volume":"51","author":"Maroun","year":"1995","journal-title":"Teratology"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrneurol.2015.143","article-title":"Type I interferon dysregulation and neurological disease","volume":"11","author":"McGlasson","year":"2015","journal-title":"Nature Reviews Neurology"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s40265-015-0470-2","article-title":"Ruxolitinib: A review in polycythaemia vera","volume":"75","author":"McKeage","year":"2015","journal-title":"Drugs"},{"key":"bib48","doi-asserted-by":"publisher","DOI":"10.1186\/1559-0275-11-32","article-title":"Validation of a blood protein signature for non-small cell lung cancer","volume":"11","author":"Mehan","year":"2014","journal-title":"Clinical Proteomics"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/ncb3075","article-title":"White-to-brown metabolic conversion of human adipocytes by JAK inhibition","volume":"17","author":"Moisan","year":"2015","journal-title":"Nature Cell Biology"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/366129a0","article-title":"The protein tyrosine kinase JAK1 complements defects in interferon-alpha\/beta and -gamma signal transduction","volume":"366","author":"M\u00fcller","year":"1993","journal-title":"Nature"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1158\/1078-0432.CCR-15-2781","article-title":"A multi-institution phase I trial of ruxolitinib in patients with chronic myelomonocytic leukemia (CMML)","volume":"22","author":"Padron","year":"2016","journal-title":"Clinical Cancer Research"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nbd.2015.03.014","article-title":"mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy","volume":"84","author":"Perluigi","year":"2015","journal-title":"Neurobiology of Disease"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40265-015-0351-8","article-title":"Ruxolitinib: a review of its use in patients with myelofibrosis","volume":"75","author":"Plosker","year":"2015","journal-title":"Drugs"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1182\/blood-2009-04-214957","article-title":"Preclinical characterization of the selective JAK1\/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms","volume":"115","author":"Quint\u00e1s-Cardama","year":"2010","journal-title":"Blood"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00281-010-0205-0","article-title":"Immunopathology of the human pancreas in type-I diabetes","volume":"33","author":"Richardson","year":"2011","journal-title":"Seminars in Immunopathology"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1111\/bjh.13096","article-title":"Haematopoietic development and leukaemia in Down syndrome","volume":"167","author":"Roberts","year":"2014","journal-title":"British Journal of Haematology"},{"key":"bib57","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bau009","article-title":"AnaLysis of Expression on human chromosome 21, ALE-HSA21: a pilot integrated web resource","volume":"2014","author":"Scarpato","year":"2014","journal-title":"Database"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/jcph.354","article-title":"The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1\/2 inhibitor, in healthy volunteers","volume":"54","author":"Shi","year":"2014","journal-title":"Journal of Clinical Pharmacology"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/0092-8674(94)90357-3","article-title":"Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions","volume":"76","author":"Shuai","year":"1994","journal-title":"Cell"},{"key":"bib61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1128\/JVI.25.1.319-325.1978","article-title":"Presence of human chromosome 21 alone is sufficient for hybrid cell sensitivity to human interferon","volume":"25","author":"Slate","year":"1978","journal-title":"Journal of Virology"},{"key":"bib62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137093","article-title":"Risk of major cardiovascular events in people with Down syndrome","volume":"10","author":"Sobey","year":"2015","journal-title":"PloS One"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.3324\/haematol.2015.135418","article-title":"Activity of the Janus kinase inhibitor ruxolitinib in chronic lymphocytic leukemia: results of a phase II trial","volume":"101","author":"Spaner","year":"2016","journal-title":"Haematologica"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1126\/science.8272873","article-title":"Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components","volume":"263","author":"Stahl","year":"1994","journal-title":"Science"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/leu.2013.33","article-title":"AKT collaborates with ERG and Gata1s to dysregulate megakaryopoiesis and promote AMKL","volume":"27","author":"Stankiewicz","year":"2013","journal-title":"Leukemia"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nchembio.965","article-title":"ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53","volume":"8","author":"Sullivan","year":"2012","journal-title":"Nature Chemical Biology"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbi.2009.09.016","article-title":"A direct cross-talk between interferon-\u03b3 and sonic hedgehog signaling that leads to the proliferation of neuronal precursor cells","volume":"24","author":"Sun","year":"2010","journal-title":"Brain, Behavior, and Immunity"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1126\/science.186.4158.61","article-title":"Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state","volume":"186","author":"Tan","year":"1974","journal-title":"Science"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000130262","article-title":"Proceedings: The genetics of the antiviral state in human cells","volume":"13","author":"Tan","year":"1974","journal-title":"Cytogenetics and Cell Genetics"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.cyto.2012.08.020","article-title":"Expression of interferon-\u03b3, interferon-\u03b1 and related genes in individuals with Down syndrome and periodontitis","volume":"60","author":"Tanaka","year":"2012","journal-title":"Cytokine"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1128\/JVI.02640-06","article-title":"Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy","volume":"81","author":"Taylor","year":"2007","journal-title":"Journal of Virology"},{"key":"bib72","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1056\/NEJMc1109555","article-title":"Long-term outcome of treatment with ruxolitinib in myelofibrosis","volume":"365","author":"Tefferi","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"bib73","doi-asserted-by":"publisher","first-page":"33369","DOI":"10.1074\/jbc.M111.225680","article-title":"Tripartite motif 24 (Trim24\/Tif1\u03b1) tumor suppressor protein is a novel negative regulator of interferon (IFN)\/signal transducers and activators of transcription (STAT) signaling pathway acting through retinoic acid receptor \u03b1 (Rar\u03b1) inhibition","volume":"286","author":"Tisserand","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"bib74","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/18715273113126660184","article-title":"The Akt-mTOR pathway in Down's syndrome: the potential use of rapamycin\/rapalogs for treating cognitive deficits","volume":"13","author":"Troca-Mar\u00edn","year":"2014","journal-title":"CNS & Neurological Disorders - Drug Targets"},{"key":"bib75","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/sj.leu.2402365","article-title":"Detection of mycoplasma in leukemia-lymphoma cell lines using polymerase chain reaction","volume":"16","author":"Uphoff","year":"2002","journal-title":"Leukemia"},{"key":"bib76","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrc2819","article-title":"MYC as a regulator of ribosome biogenesis and protein synthesis","volume":"10","author":"van Riggelen","year":"2010","journal-title":"Nature Reviews Cancer"},{"key":"bib77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074184","article-title":"Expression signature as a biomarker for prenatal diagnosis of trisomy 21","volume":"8","author":"Volk","year":"2013","journal-title":"PLoS One"},{"key":"bib78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009753","article-title":"Dissecting interferon-induced transcriptional programs in human peripheral blood cells","volume":"5","author":"Waddell","year":"2010","journal-title":"PLoS One"},{"key":"bib79","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012351","article-title":"Tinkering with translation: protein synthesis in virus-infected cells","volume":"5","author":"Walsh","year":"2013","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"bib80","doi-asserted-by":"publisher","first-page":"W77","DOI":"10.1093\/nar\/gkt439","article-title":"WEB-based GEne SeT anaLysis toolkit (WebGestalt): update 2013","volume":"41","author":"Wang","year":"2013","journal-title":"Nucleic Acids Research"},{"key":"bib81","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1093\/bioinformatics\/bts356","article-title":"RSeQC: quality control of RNA-seq experiments","volume":"28","author":"Wang","year":"2012","journal-title":"Bioinformatics"},{"key":"bib82","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/sj.mp.4001600","article-title":"IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity","volume":"10","author":"Wichers","year":"2005","journal-title":"Molecular Psychiatry"},{"key":"bib83","first-page":"11","article-title":"The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression","volume":"29","author":"Wichers","year":"2004","journal-title":"Journal of Psychiatry & Neuroscience"},{"key":"bib84","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrn3983","article-title":"A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome","volume":"16","author":"Wiseman","year":"2015","journal-title":"Nature Reviews Neuroscience"},{"key":"bib85","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s004310051089","article-title":"Interferon alpha-2a therapy in haemangiomas of infancy: spastic diplegia as a severe complication","volume":"158","author":"W\u00f6rle","year":"1999","journal-title":"European Journal of Pediatrics"},{"key":"bib86","doi-asserted-by":"publisher","DOI":"10.1186\/ar2887","article-title":"Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFN\u03b1 antibody, in systemic lupus erythematosus","volume":"12 Suppl 1","author":"Yao","year":"2010","journal-title":"Arthritis Research & Therapy"},{"key":"bib87","doi-asserted-by":"publisher","first-page":"W741","DOI":"10.1093\/nar\/gki475","article-title":"WebGestalt: an integrated system for exploring gene sets in various biological contexts","volume":"33","author":"Zhang","year":"2005","journal-title":"Nucleic Acids Research"},{"key":"bib88","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nri3845","article-title":"Type I interferons in anticancer immunity","volume":"15","author":"Zitvogel","year":"2015","journal-title":"Nature Reviews Immunology"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/16220\/elife-16220-v2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/16220\/elife-16220-v2.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/16220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T20:52:33Z","timestamp":1697057553000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/16220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,29]]},"references-count":88,"alternative-id":["10.7554\/eLife.16220"],"URL":"https:\/\/doi.org\/10.7554\/elife.16220","archive":["CLOCKSS"],"relation":{"is-supplemented-by":[{"id-type":"uri","id":"http:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE79842","asserted-by":"subject"},{"id-type":"uri","id":"http:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE79840","asserted-by":"subject"},{"id-type":"uri","id":"http:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE84531","asserted-by":"subject"},{"id-type":"uri","id":"http:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE84526","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.16220.036","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.16220.035","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,29]]},"article-number":"e16220"}}